Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.
It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...
July 2023 - Molecular Pathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Molecular Pathology.
Malabsorption - Mayo Clinic Laboratories
Stool testing is a critical component of diagnosing EPI and Mayo Clinic Laboratories offers multiple tests to help clinicians in their work-up of these patients.
Diagnosis and inflammation monitoring - Insights
Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.
Learn how digital imaging can provide a clearer picture of difficult cases to assist with interpretations.
Peroxisomal biogenesis and metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ testing for peroxisomal biogenesis and metabolism disorders can assist in the identification of these sometimes fatal conditions.
Learn more about how Mayo Clinic Laboratories’ genetic testing for pulmonary conditions can provide diagnostic confirmation for an array of inherited illnesses.
Exploratory testing - Insights
Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.
Learn more about how Mayo Clinic Laboratories’ testing can assist in diagnosis and differentiation of porphyrias and help guide treatment decisions